Amundi Stoxx Europe 600 UCITS ETF C (GBP) | MEUDRegister to Unlock Ratings |
Performance History | 31/08/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | - | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 25/09/2024 | GBX 20185.00 | |
Day Change | 0.11% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 4320 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | LU0908500753 | |
Fund Size (Mil) 24/09/2024 | EUR 8949.20 | |
Share Class Size (Mil) 24/09/2024 | EUR 8838.23 | |
Ongoing Charge 02/04/2024 | 0.07% |
Investment Objective: Amundi Stoxx Europe 600 UCITS ETF C (GBP) | MEUD |
To track the performance of STOXX Europe 600 Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. The exposure to the Index will be achieved through a direct replication, mainly by making direct investments in transferable securities and/or other eligible assets representing the Index constituents in a proportion extremely close to their proportion in the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 08/02/2024 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
STOXX Europe 600 NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Stoxx Europe 600 UCITS ETF C (GBP) | MEUD | 23/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 3.31 |
ASML Holding NV | Technology | 2.65 |
Nestle SA | Consumer Defensive | 2.12 |
AstraZeneca PLC | Healthcare | 1.99 |
SAP SE | Technology | 1.95 |
Increase Decrease New since last portfolio | ||
Amundi Stoxx Europe 600 UCITS ETF C (GBP) | MEUD |